High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14(+)CD16(++) monocytes in patients with inflammatory disorders

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)11-12
Number of pages2
JournalClinical Immunology
Volume145
Issue number1
DOIs
Publication statusPublished - 2012

Cite this